• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-17通过TRIM31依赖的MEF2C K63连接的多聚泛素化触发非小细胞肺癌细胞中程序性死亡配体1(PD-L1)基因转录。

IL-17 triggers PD-L1 gene transcription in NSCLC cells via TRIM31-dependent MEF2C K63-linked polyubiquitination.

作者信息

Ying Shuai, Wu Ningxia, Ruan Yuting, Ge Wen, Ma Pei, Xu Tongpeng, Shu Yongqian, Wang Yingwei, Qiu Wen, Zhao Chenhui

机构信息

Department of Immunology, Nanjing Medical University, Nanjing, 211166, China.

Department of Laboratory Medicine, Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214023, China.

出版信息

BMC Cancer. 2025 Jan 14;25(1):81. doi: 10.1186/s12885-025-13473-w.

DOI:10.1186/s12885-025-13473-w
PMID:39810133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11731414/
Abstract

BACKGROUND

Non-small cell lung cancer (NSCLC) is a disease related to inflammation. Proinflammatory cytokines such as interleukin 17 (IL-17) can induce cancer cell proliferation, metastasis and immune escape. Although NSCLC immune escape is partly due to the interaction between PD-1 and PD-L1 and PD-L1 expression can be upregulated in cancer cells upon stimulation with IL-17, the underlying mechanism of IL-17-triggered PD-L1 gene transcription in NSCLC cells remains elusive.

METHODS

RT‒PCR, real-time PCR, and IB were used to assess the levels of PD-L1, MEF2C, and TRIM31 in NSCLC tissues as well as in IL-17-stimulated H1299 or PC9 cells. Bioinformatics analysis, luciferase assays, and ChIP were utilized to investigate the transcriptional mechanism of the PD-L1 gene. Co-IP/IB was used to examine the interaction between MEF2C and PD-L1, including MEF2C ubiquitination. IHC staining was carried out to analyse the expression of IL-17RA, MEF2C, TRIM31, and PD-L1 in NSCLC tissue arrays. The corresponding plasmids were constructed and identified. An isograft model was used to verify the findings in vitro.

RESULTS

PD-L1, MEF2C and TRIM31 expression levels were increased in NSCLC tissues and NSCLC cells exposed to IL-17. Mechanistically, MEF2C could bind to the - 778 to -475 nt and - 336 to -97 nt regions of the PD-L1 promoter. TRIM31 could mediate MEF2C K63-linked polyubiquitination at Lys 25, increasing MEF2C recruitment to the PD-L1 promoter and PD-L1 gene transcription. MEF2C, TRIM31 or PD-L1 gene silencing effectively suppressed MEF2C K63-linked polyubiquitination, PD-L1 induction and NSCLC growth in mice inoculated with Lewis lung cancer (LLC) cells transfected with the corresponding shRNA and treated with IL-17.

CONCLUSION

IL-17 induces PD-L1 gene transcription in NSCLC cells through TRIM31-dependent MEF2C K63-linked polyubiquitination.

摘要

背景

非小细胞肺癌(NSCLC)是一种与炎症相关的疾病。白细胞介素17(IL-17)等促炎细胞因子可诱导癌细胞增殖、转移和免疫逃逸。尽管NSCLC免疫逃逸部分归因于PD-1与PD-L1之间的相互作用,且IL-17刺激后癌细胞中PD-L1表达可上调,但IL-17触发NSCLC细胞中PD-L1基因转录的潜在机制仍不清楚。

方法

采用逆转录聚合酶链反应(RT-PCR)、实时荧光定量PCR和免疫印迹法(IB)评估NSCLC组织以及IL-17刺激的H1299或PC9细胞中PD-L1、MEF2C和TRIM31的水平。利用生物信息学分析、荧光素酶报告基因检测和染色质免疫沉淀法(ChIP)研究PD-L1基因的转录机制。采用免疫共沉淀/免疫印迹法(Co-IP/IB)检测MEF2C与PD-L1之间的相互作用,包括MEF2C的泛素化。进行免疫组化染色分析NSCLC组织芯片中IL-17RA、MEF2C、TRIM31和PD-L1的表达。构建并鉴定相应质粒。采用同基因移植模型在体外验证研究结果。

结果

NSCLC组织和暴露于IL-17的NSCLC细胞中,PD-L1、MEF2C和TRIM31表达水平升高。机制上,MEF2C可与PD-L1启动子的-778至-475 nt和-336至-97 nt区域结合。TRIM31可介导MEF2C在赖氨酸25位点发生K63连接的多聚泛素化,增加MEF2C对PD-L1启动子的募集及PD-L1基因转录。MEF2C、TRIM31或PD-L1基因沉默可有效抑制接种用相应短发夹RNA(shRNA)转染并经IL-17处理的Lewis肺癌(LLC)细胞的小鼠中MEF2C的K63连接多聚泛素化、PD-L1诱导及NSCLC生长。

结论

IL-17通过TRIM31依赖的MEF2C K63连接多聚泛素化诱导NSCLC细胞中PD-L1基因转录。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/304d1090c97f/12885_2025_13473_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/90f59993f003/12885_2025_13473_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/a54264473293/12885_2025_13473_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/c909f9ba53a0/12885_2025_13473_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/cf5e43ef97e3/12885_2025_13473_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/d85d85da494a/12885_2025_13473_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/14a87c7154ed/12885_2025_13473_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/304d1090c97f/12885_2025_13473_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/90f59993f003/12885_2025_13473_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/a54264473293/12885_2025_13473_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/c909f9ba53a0/12885_2025_13473_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/cf5e43ef97e3/12885_2025_13473_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/d85d85da494a/12885_2025_13473_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/14a87c7154ed/12885_2025_13473_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/849e/11731414/304d1090c97f/12885_2025_13473_Fig8_HTML.jpg

相似文献

1
IL-17 triggers PD-L1 gene transcription in NSCLC cells via TRIM31-dependent MEF2C K63-linked polyubiquitination.白细胞介素-17通过TRIM31依赖的MEF2C K63连接的多聚泛素化触发非小细胞肺癌细胞中程序性死亡配体1(PD-L1)基因转录。
BMC Cancer. 2025 Jan 14;25(1):81. doi: 10.1186/s12885-025-13473-w.
2
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.ILT4 抑制可预防 TAM 和功能失调 T 细胞介导的免疫抑制,并增强 EGFR 激活的 NSCLC 中抗 PD-L1 治疗的疗效。
Theranostics. 2021 Jan 19;11(7):3392-3416. doi: 10.7150/thno.52435. eCollection 2021.
3
LKB1 dictates sensitivity to immunotherapy through Skp2-mediated ubiquitination of PD-L1 protein in non-small cell lung cancer.在非小细胞肺癌中,LKB1通过Skp2介导的PD-L1蛋白泛素化决定对免疫疗法的敏感性。
J Immunother Cancer. 2024 Dec 18;12(12):e009444. doi: 10.1136/jitc-2024-009444.
4
The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.去泛素化酶 USP10 可恢复 PTEN 的活性并抑制非小细胞肺癌细胞的增殖。
J Biol Chem. 2021 Sep;297(3):101088. doi: 10.1016/j.jbc.2021.101088. Epub 2021 Aug 18.
5
Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.TRIM31 的缺失通过调节 p53 的 K48-和 K63 连接泛素化来促进乳腺癌的进展。
Cell Death Dis. 2021 Oct 14;12(10):945. doi: 10.1038/s41419-021-04208-3.
6
Inhibition of NSUN3 suppresses immune escape in non-small cell lung cancer through stabilizing PD-L1 in a 5-methyladenosine dependent way.抑制NSUN3通过以5-甲基腺苷依赖的方式稳定PD-L1来抑制非小细胞肺癌中的免疫逃逸。
Clinics (Sao Paulo). 2025 Apr 24;80:100662. doi: 10.1016/j.clinsp.2025.100662. eCollection 2025.
7
N-methyladenosine-modified circIGF2BP3 inhibits CD8 T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer.N6-甲基腺苷修饰的环状 IGF2BP3 通过促进非小细胞肺癌中 PD-L1 的去泛素化来抑制 CD8 T 细胞反应,从而促进肿瘤免疫逃逸。
Mol Cancer. 2021 Aug 20;20(1):105. doi: 10.1186/s12943-021-01398-4.
8
DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.DCUN1D1 通过激活 FAK 信号和上调非小细胞肺癌中的 PD-L1 促进肿瘤转移。
Exp Cell Res. 2019 Jan 15;374(2):304-314. doi: 10.1016/j.yexcr.2018.12.001. Epub 2018 Dec 4.
9
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer.在PD-L1高表达的肺癌中,细胞内源性PD-L1信号通过IL-6/Jak/Stat3途径驱动髓源性抑制细胞产生免疫抑制作用。
J Immunother Cancer. 2025 Mar 6;13(3):e010612. doi: 10.1136/jitc-2024-010612.
10
Ubiquitin C-terminal hydrolase L1 promotes expression of programmed cell death-ligand 1 in non-small-cell lung cancer cells.泛素羧基末端水解酶L1促进非小细胞肺癌细胞中程序性细胞死亡配体1的表达。
Cancer Sci. 2020 Sep;111(9):3174-3183. doi: 10.1111/cas.14529. Epub 2020 Jul 6.

本文引用的文献

1
Multi‑omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma.基于肺癌腺癌细胞相关配体 - 受体基因的多组学鉴定特征。
BMC Cancer. 2024 Sep 12;24(1):1138. doi: 10.1186/s12885-024-12911-5.
2
Causal association between immune cells and lung cancer risk: a two-sample bidirectional Mendelian randomization analysis.免疫细胞与肺癌风险之间的因果关系:两样本双向孟德尔随机化分析。
Front Immunol. 2024 Jun 19;15:1433299. doi: 10.3389/fimmu.2024.1433299. eCollection 2024.
3
IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer.
IL-17A 促进非小细胞肺癌的肿瘤发生并上调 PD-L1 表达。
J Transl Med. 2023 Nov 17;21(1):828. doi: 10.1186/s12967-023-04365-3.
4
IL-17 induces non-small cell lung cancer metastasis via GCN5-dependent SOX4 acetylation enhancing MMP9 gene transcription and expression.IL-17 通过 GCN5 依赖性 SOX4 乙酰化促进 MMP9 基因转录和表达诱导非小细胞肺癌转移。
Mol Carcinog. 2023 Sep;62(9):1399-1416. doi: 10.1002/mc.23585. Epub 2023 Jun 9.
5
TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion.TRIM56 通过 IQGAP1-CDC42 信号轴促进神经胶质瘤细胞迁移和侵袭。
Cell Death Dis. 2023 Mar 4;14(3):178. doi: 10.1038/s41419-023-05702-6.
6
TRIM31: A molecule with a dual role in cancer.TRIM31:一种在癌症中具有双重作用的分子。
Front Oncol. 2022 Dec 22;12:1047177. doi: 10.3389/fonc.2022.1047177. eCollection 2022.
7
Integrative Bioinformatics Analysis Reveals That miR-524-5p/MEF2C Regulates Bone Metastasis in Prostate Cancer and Breast Cancer.综合生物信息学分析揭示 miR-524-5p/MEF2C 调控前列腺癌和乳腺癌的骨转移。
Comput Math Methods Med. 2022 Sep 10;2022:5211329. doi: 10.1155/2022/5211329. eCollection 2022.
8
Exosomal MEF2C's Association With the Progression of CRC in Regulating CD36 Transcription.外泌体MEF2C在调节CD36转录中与结直肠癌进展的关联
Altern Ther Health Med. 2023 Jan;29(1):198-209.
9
Transcriptional Plasticity Drives Leukemia Immune Escape.转录可塑性驱动白血病免疫逃逸。
Blood Cancer Discov. 2022 Sep 6;3(5):394-409. doi: 10.1158/2643-3230.BCD-21-0207.
10
MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymus.MEF2C 抑制淋巴谱系决定并驱动胸腺中的白血病。
JCI Insight. 2022 Jul 8;7(13):e150363. doi: 10.1172/jci.insight.150363.